Ontology list
Cellular componentprotein complex - GO:0043234; nucleus - GO:0005634; intracellular organelle - GO:0043229; cellular_component - GO:0005575; membrane-bounded organelle - GO:0043227; intracellular part - GO:0044424; organelle - GO:0043226; macromolecular complex - GO:0032991; cell part - GO:0044464; intracellular membrane-bounded organelle - GO:0043231; transcription factor complex - GO:0005667;
Molecular functionregulatory region nucleic acid binding - GO:0001067; rna polymerase ii regulatory region dna binding - GO:0001012; transcriptional repressor activity; RNA polymerase II transcription regulatory region sequence-specific binding - GO:0001227; rna polymerase ii core promoter proximal region sequence-specific dna binding - GO:0000978; RNA polymerase II core promoter proximal region sequence-specific DNA binding - GO:0000978; rna polymerase ii transcription regulatory region sequence-specific dna binding transcription factor activity involved in negative regulation of transcription - GO:0001227; nucleic acid binding - GO:0003676; binding - GO:0005488; rna polymerase ii core promoter proximal region sequence-specific dna binding transcription factor activity involved in negative regulation of transcription - GO:0001078; regulatory region dna binding - GO:0000975; dna binding - GO:0003677; core promoter proximal region sequence-specific dna binding - GO:0000987; sequence-specific dna binding transcription factor activity - GO:0003700; molecular_function - GO:0003674; transcription regulatory region dna binding - GO:0044212; nucleic acid binding transcription factor activity - GO:0001071; core promoter proximal region dna binding - GO:0001159; heterocyclic compound binding - GO:1901363; rna polymerase ii core promoter proximal region sequence-specific dna binding transcription factor activity - GO:0000982; sequence-specific DNA binding - GO:0043565; RNA polymerase II transcription factor activity; sequence-specific DNA binding - GO:0000981; rna polymerase ii regulatory region sequence-specific dna binding - GO:0000977; transcription regulatory region sequence-specific dna binding - GO:0000976; protein binding - GO:0005515; organic cyclic compound binding - GO:0097159; sequence-specific dna binding rna polymerase ii transcription factor activity - GO:0000981; DNA binding - GO:0003677; sequence-specific dna binding - GO:0043565;
Biological processcellular response to stress - GO:0033554; regulation of developmental growth - GO:0048638; positive regulation of developmental growth - GO:0048639; regulation of cell proliferation - GO:0042127; negative regulation of embryonic development - GO:0045992; negative regulation of rna metabolic process - GO:0051253; positive regulation of biological process - GO:0048518; pharynx development - GO:0060465; negative regulation of nucleobase-containing compound metabolic process - GO:0045934; single-organism process - GO:0044699; nitrogen compound metabolic process - GO:0006807; rna biosynthetic process - GO:0032774; primary metabolic process - GO:0044238; regulation of nucleic acid-templated transcription - GO:1903506; regulation of developmental process - GO:0050793; macromolecule metabolic process - GO:0043170; eye morphogenesis - GO:0048592; negative regulation of macromolecule biosynthetic process - GO:0010558; negative regulation of cellular macromolecule biosynthetic process - GO:2000113; positive regulation of developmental process - GO:0051094; Notch signaling pathway - GO:0007219; cardiac muscle tissue development - GO:0048738; embryonic camera-type eye morphogenesis - GO:0048596; regulation of muscle tissue development - GO:1901861; regulation of rna metabolic process - GO:0051252; outflow tract septum morphogenesis - GO:0003148; atrioventricular canal development - GO:0036302; positive regulation of multicellular organismal process - GO:0051240; regulation of cardiac chamber formation - GO:1901210; regulation of gene expression - GO:0010468; organic cyclic compound biosynthetic process - GO:1901362; regulation of striated muscle tissue development - GO:0016202; positive regulation of striated muscle tissue development - GO:0045844; positive regulation of cardiac muscle cell proliferation - GO:0060045; regulation of primary metabolic process - GO:0080090; positive regulation of cardiac muscle tissue development - GO:0055025; nucleobase-containing compound metabolic process - GO:0006139; heterocycle biosynthetic process - GO:0018130; metabolic process - GO:0008152; nucleic acid metabolic process - GO:0090304; embryonic organ morphogenesis - GO:0048562; cellular senescence - GO:0090398; organ morphogenesis - GO:0009887; aromatic compound biosynthetic process - GO:0019438; nucleic acid-templated transcription - GO:0097659; cardiac septum morphogenesis - GO:0060411; regulation of nitrogen compound metabolic process - GO:0051171; regulation of transcription from rna polymerase ii promoter - GO:0006357; positive regulation of muscle organ development - GO:0048636; negative regulation of cellular biosynthetic process - GO:0031327; cell fate determination - GO:0001709; regulation of cellular biosynthetic process - GO:0031326; negative regulation of developmental process - GO:0051093; regulation of cardiac muscle tissue growth - GO:0055021; cell aging - GO:0007569; muscle cell fate determination - GO:0007521; regulation of metabolic process - GO:0019222; embryonic morphogenesis - GO:0048598; regulation of heart morphogenesis - GO:2000826; regulation of cardiac chamber morphogenesis - GO:1901219; regulation of multicellular organismal development - GO:2000026; negative regulation of transcription from rna polymerase ii promoter - GO:0000122; positive regulation of cellular process - GO:0048522; embryonic eye morphogenesis - GO:0048048; growth - GO:0040007; regulation of macromolecule metabolic process - GO:0060255; negative regulation of cellular process - GO:0048523; negative regulation of transcription; dna-templated - GO:0045892; regulation of growth - GO:0040008; outflow tract morphogenesis - GO:0003151; cellular macromolecule biosynthetic process - GO:0034645; embryonic heart tube development - GO:0035050; negative regulation of cardiac chamber morphogenesis - GO:1901220; regulation of cellular process - GO:0050794; regulation of macromolecule biosynthetic process - GO:0010556; cellular metabolic process - GO:0044237; anatomical structure development - GO:0048856; regulation of organ morphogenesis - GO:2000027; tissue morphogenesis - GO:0048729; macromolecule biosynthetic process - GO:0009059; positive regulation of organ growth - GO:0046622; aorta morphogenesis - GO:0035909; positive regulation of muscle tissue development - GO:1901863; response to stimulus - GO:0050896; mammary placode formation - GO:0060596; regulation of anatomical structure morphogenesis - GO:0022603; nucleobase-containing compound biosynthetic process - GO:0034654; developmental process - GO:0032502; regulation of cardiac muscle tissue development - GO:0055024; negative regulation of cellular metabolic process - GO:0031324; negative regulation of transcription; DNA-templated - GO:0045892; cellular macromolecule metabolic process - GO:0044260; single-organism cellular process - GO:0044763; biological regulation - GO:0065007; regulation of muscle organ development - GO:0048634; negative regulation of gene expression - GO:0010629; positive regulation of heart growth - GO:0060421; negative regulation of rna biosynthetic process - GO:1902679; anatomical structure morphogenesis - GO:0009653; cellular biosynthetic process - GO:0044249; aging - GO:0007568; regulation of multicellular organismal process - GO:0051239; regulation of transcription from rna polymerase ii promoter involved in heart development - GO:1901213; negative regulation of macromolecule metabolic process - GO:0010605; regulation of cellular macromolecule biosynthetic process - GO:2000112; response to stress - GO:0006950; mesenchyme morphogenesis - GO:0072132; rna metabolic process - GO:0016070; regulation of organ growth - GO:0046620; regulation of heart growth - GO:0060420; palate development - GO:0060021; organic cyclic compound metabolic process - GO:1901360; embryonic digit morphogenesis - GO:0042733; regulation of embryonic development - GO:0045995; cellular response to stimulus - GO:0051716; negative regulation of nucleic acid-templated transcription - GO:1903507; cellular developmental process - GO:0048869; positive regulation of cardiac muscle tissue growth - GO:0055023; developmental growth - GO:0048589; regulation of biological process - GO:0050789; artery morphogenesis - GO:0048844; heterocycle metabolic process - GO:0046483; endocardial cushion morphogenesis - GO:0003203; striated muscle tissue development - GO:0014706; developmental growth involved in morphogenesis - GO:0060560; sensory organ morphogenesis - GO:0090596; cellular nitrogen compound biosynthetic process - GO:0044271; blood vessel morphogenesis - GO:0048514; regulation of cardiac muscle cell proliferation - GO:0060043; regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation - GO:0003256; regulation of nucleobase-containing compound metabolic process - GO:0019219; positive regulation of growth - GO:0045927; negative regulation of heart looping - GO:1901208; negative regulation of multicellular organismal process - GO:0051241; regulation of cellular metabolic process - GO:0031323; regulation of rna biosynthetic process - GO:2001141; regulation of transcription; dna-templated - GO:0006355; regulation of heart looping - GO:1901207; biosynthetic process - GO:0009058; regulation of biosynthetic process - GO:0009889; negative regulation of transcription from RNA polymerase II promoter - GO:0000122; heart looping - GO:0001947; regulation of heart contraction - GO:0008016; organic substance metabolic process - GO:0071704; single-organism developmental process - GO:0044767; negative regulation of biosynthetic process - GO:0009890; negative regulation of metabolic process - GO:0009892; anatomical structure formation involved in morphogenesis - GO:0048646; tissue development - GO:0009888; transcription; dna-templated - GO:0006351; cellular aromatic compound metabolic process - GO:0006725; organic substance biosynthetic process - GO:1901576; negative regulation of biological process - GO:0048519; cellular nitrogen compound metabolic process - GO:0034641; muscle tissue development - GO:0060537; ectodermal placode formation - GO:0060788; cellular process - GO:0009987; negative regulation of cardiac chamber formation - GO:1901211; positive regulation of cell proliferation - GO:0008284; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation - GO:0003256; biological_process - GO:0008150; negative regulation of nitrogen compound metabolic process - GO:0051172;